Hematopoietic SCT activity in Asia: A report from the Asia-Pacific Blood and Marrow Transplantation Group

Bone Marrow Transplantation

Volumn 45, Issue 12, 2010, Pages 1682-1691

  Yoshimi, A ^a   Suzuki, R ^a   Atsuta, Y ^a   Iida, M ^b   Lu, D P ^c   Tong, W ^c   Ghavamzadeh, A ^d   Alimoghaddam, K ^d   Lie, A K W ^e   Liang, R ^e   Chan, L L ^f   Haipeng, L ^f   Tan, P L ^g   Hwang, W Y K ^h   Chiou, T J ⁱ   Chen, P M ^j   Van Binh, T ^k   Minh, N N ^l   Min, C K ^m   Hwang, T J ⁿ   Kodera, Y ^b   more..

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AICHI MEDICAL UNIVERSITY   (Japan)

^c Beijing Daopei Hospital   (China)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e QUEEN MARY HOSPITAL   (Hong Kong)

^f Malaysia National Transplant Registry   (Malaysia)

^g NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^h SINGAPORE GENERAL HOSPITAL   (Singapore)

ⁱ NATIONAL YANG MING UNIVERSITY   (Taiwan)

^j TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^k Blood Transfusion and Hematology Center   (Viet Nam)

^l Hue Regional Hematology and Blood Transfusion Center   (Viet Nam)

^m The Catholic University of Korea   (South Korea)

ⁿ Chonnam National University Medical School   (South Korea)

more..

Author keywords

Asia; hematopoietic SCT; registry

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ASIA; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DONOR; HEALTH SURVEY; HEMOGLOBINOPATHY; HUMAN; IRAN; JAPAN; LYMPHOMA; MAJOR CLINICAL STUDY; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; SOLID TUMOR; TREATMENT INDICATION; VIET NAM;

ASIA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS;

EID: 78650199305     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2010.34     Document Type: Article

References (37)

1. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med 2006; 354: 1813-1826.
2. Ljungman P, Urbano-Ispizua A, Cavazzana-Calvo M, Demirer T, Dini G, Einsele H et al. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: Definitions and current practice in Europe. Bone Marrow Transplant 2006; 37: 439-449.
3. Imamura M, Asano S, Harada M, Ikeda Y, Kato K, Kato S et al. Current status of hematopoietic cell transplantation for adult patients with hematologic diseases and solid tumors in Japan. Int J Hematol 2006; 83: 164-178.
4. Gratwohl A, Baldomero H, Horisberger B, Schmid C, Passweg J, Urbano-Ispizua A. Current trends in hematopoietic stem cell transplantation in Europe. Blood 2002; 100: 2374-2386.
5. Wu T, Lu D-P. Blood and marrow transplantation in the People's Republic of China. Bone Marrow Transplant 2008; 42: S73-S75.
6. Chandy M. Stem cell transplantation in India. Bone Marrow Transplant 2008; 42: S81-S84.
7. Hariman H. The hematopoietic stem cell transplantation in Indonesia: An unsolved dilemma. Bone Marrow Transplant 2008; 42: S85-S88.
8. Lee J-W, Kim C-C. The activity of hematopoietic stem cell transplantation in Korea. Bone Marrow Transplant 2008; 42: S92-S95.
9. Gan GG, Teh A, Chan LL, Cheong SK, Chang KM, Ibrahim HM. Bone marrow and stem cell transplantation: Malaysian experience. Bone Marrow Transplant 2008; 42: S103-S105.
10. Shamsi TS, Hashmi K, Adil S, Ahmad P, Irfan M, Raza S et al. The stem cell transplant program in Pakistan-the first decade. Bone Marrow Transplant 2008; 42: S114-S117.
11. Baylon HG, del Rosario MLU, Tiangco BJ. The status of blood and marrow transplantation in Philippines. Bone Marrow Transplant 2008; 42: S118-S120.
12. Koh MBC, Goh YT, Tan PHC, Koh LP, Hwang WYK, Loh Y et al. Stem cell transplantation programme at Singapore General Hospital. Bone Marrow Transplant 2008; 42: S121-S124.
13. Chen P-M, Hsiao L-T, Chen M-H, Chang PM-S, Liu C-Y, Hong Y-C et al. Current status of hematopoietic stem cell transplantation in Taiwan. Bone Marrow Transplant 2008; 42: S133-S136.
14. Chen YC, Lin KH, Huang WS, Tang JL. Bone marrow transplantin Taiwan: An overview. Bone Marrow Transplant 1994; 13: 705-708.
15. Chen PM, Tzeng CH, Fan FS, Hsieh RK, Wei CH. Bone marrow transplantation in Taiwan: Low inciDence of acute GVHD in patients with hematologic malignancies and severe aplastic anemia. Bone Marrow Transplant 1994; 13: 709-711.
16. Tzeng CH, Lin JS, Chen PM, Hu HY, Lyou JY, Chen YR. Allogeneic peripheral blood stem cell transplantation: The Taiwan experience. Transfusion 1997; 37: 244-246.
17. Shaw CK, Lin CL, Li CC, Lee TD, Tseng WP. Marrow donor registry and bone marrow transplantation from unrelated donors in Taiwan: Initial experience of the Tzu Chi Taiwan Marrow Donor Registry (TCTMDR). Bone Marrow Transplant 1999; 23: 727-730.
18. Issaragrisil S. Hematopoietic stem cell transplantation in Thailand. Bone Marrow Transplant 2008; 42: S137-S138.
19. Issaragrisil S. Hematopoietic stem cell transplantation in Thailand. Bone Marrow Transplant 1994; 13: 721-723.
20. Kim DJ, Kim CC, Kim BK, Kim DW, Lee JW, Jin JY et al. Allogeneic bone marrow transplantation in Korea: 1982-1992. Bone Marrow Transplant 1994; 13: 717-719.
21. Van Be T, Van Binh T, Binh NT, Tuan TQ, Nghia H, Hien BM. Current status of hematopoietic stem cell transplantations in Vietnam. Bone Marrow Transplant 2008; 42: S146-S148.
22. Atsuta Y, Suzuki R, Yoshimi A, Gondo H, Tanaka J, Hiraoka A et al. Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP system. Int J Hematol 2007; 86: 269-274.
23. Lu DP, Dong L, Wu T, Huang XJ, Zhang MJ, Han W et al. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/ haploiDentical blood and marrow transplantation can achieve comparable outcomes with HLA-iDentical sibling transplantation. Blood 2006; 107: 3065-3073.
24. Kodera Y, Hiraoka A, Sakamaki H, Kigasawa H, Tabuchi K, Suzuki R et al. (eds). The Japan Society for Hematopoietic Cell Transplantation Annual Report of Nationwide Survey 2007. Vol 12. The Japan Society for Hematopoietic Cell Transplantation, Nagoya, Japan, 2008.
25. Gratwohl A, Passweg J, Baldomero H, Horisberger B, Urbano-Ispizua A. Economics, health care systems and utilization of haematopoietic stem cell transplants in Europe. Br J Haematol 2002; 117: 451-468.
26. Gratwohl A, Baldomero H, Frauendorfer K, Rocha V, Apperley J, Niederwieser D. The EBMT activity survey 2006 on hematopoietic stem cell transplantation: Focus on the use of cord blood products. Bone Marrow Transplant 2008; 41: 687-705.
27. Gratwohl A, Baldomero H, Frauendorfer K, Urbano-Ispizua A, Niederwieser D. Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: Focus on increasing use of unrelated donors. Bone Marrow Transplant 2007; 39: 71-87.
28. Morishima Y, Kodera Y, Hirabayashi N, Tanimoto M, Matsuyama T, Horibe K et al. Low inciDence of acute GVHD in patients transplanted with marrow from HLA-A,B,DRcompatible unrelated donors among Japanese. Bone Marrow Transplant 1995; 15: 235-239.
29. Gratwohl A, Baldomero H, SchwenDener A, Gratwohl M, Urbano-Ispizua A, Frauendorfer K. Hematopoietic stem cell transplants for chronic myeloid leukemia in Europe-impact of cost considerations. Leukemia 2007; 21: 383-386.
30. Reed SD, Anstrom KJ, Ludmer JA, GlenDenning GA, Schulman KA. Cost-effectiveness of imatinib versus interferon- alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia. Cancer 2004; 101: 2574-2583.
31. Stadtmauer EA, O'Neill A, Goldstein LJ, Crilley PA, Mangan KF, Ingle JN et al. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. N Engl J Med 2000; 342: 1069-1076.
32. Roche H, Viens P, Biron P, Lotz JP, Asselain B. High-dose chemotherapy for breast cancer: The French PEGASE experience. Cancer Control 2003; 10: 42-47.
33. Berry DA, Broadwater G, Klein JP, Antman K, Aisner J, Bitran J et al. High-dose versus standard chemotherapy in metastatic breast cancer: Comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry. J Clin Oncol 2002; 20: 743-750.
34. Vogl DT, Stadtmauer EA. High-dose chemotherapy and autologous hematopoietic stem cell transplantation for metastatic breast cancer: A therapy whose time has passed. Bone Marrow Transplant 2006; 37: 985-987.
35. Gratwohl A, Baldomero H, Frauendorfer K, Urbano-Ispizua A. EBMT activity survey 2004 and changes in disease indication over the past 15 years. Bone Marrow Transplant 2006; 37: 1069-1085.
36. Gratwohl A, Baldomero H, Schmid O, Horisberger B, Bargetzi M, Urbano-Ispizua A. Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: A report of the EBMT activity survey 2003. Bone Marrow Transplant 2005; 36: 575-590.
37. Gratwohl A, Schmid O, Baldomero H, Horisberger B, Urbano-Ispizua A. Haematopoietic stem cell transplantation (HSCT) in Europe 2002. Changes in indication and impact of team Density. A report of the EBMT activity survey. Bone Marrow Transplant 2004; 34: 855-875.